Gene · 1902
Papers2,112
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,112
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engineering Native-like GPCR Antigens Enables Discovery of an LPA2-Blocking Antibody for Ovarian Cancer. | ACS Synth Biol | 2026 | 41476039 | PubTator, text mining | PubMed |
| The LPA2 receptor PDZ domain affects canonical Wnt signaling in colon cancer cells. | Cell Signal | 2026 | 41418976 | PubTator, text mining | PubMed |
| Distinct roles of lysophosphatidic acid (LPA) receptor signaling in regulating gastric cancer cell functions under chemical versus physiological hypoxia. | Acta Histochem | 2026 | 41265111 | PubTator, text mining | PubMed |
| A pharmacokinetics study to evaluate drug-drug interactions between fipaxalparant and concomitant medications in healthy participants. | Clin Pharmacol Drug Dev | 2026 | 41253600 | PubTator, text mining | PubMed |
| The impact of para-hydroxycinnamic acid on myofibroblast trans-differentiation in MRC-5 and A549 cell lines: in silico and in vitro evaluation. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 40828324 | PubTator, text mining | PubMed |
| Identify GDPD3 as a key regulator of epithelial-mesenchymal transition and prostate adenocarcinoma progression via the LPA/LPAR1/AKT axis: transcriptomic and experimental study. | Front Immunol | 2025 | 41562071 | PubTator, text mining | PubMed |
| Prognostic value of LPAR1 expression and methylation in low-grade gliomas: a meta-analysis of TCGA and CGGA datasets and functional validation. | BMC Cancer | 2025 | 41462160 | PubTator, text mining | PubMed |
| Unveiling the role of angiogenesis-related biomarkers in diabetic nephropathy via transcriptomics. | Diabetol Metab Syndr | 2025 | 41366482 | PubTator, text mining | PubMed |
| Lysophosphatidic Acid (LPA) Receptor Signaling Promotes the Adaptation of Malignant Cellular Functions in Highly Migratory Osteosarcoma Cells Under Hypoxic and Low-Glucose Conditions. | Cell Mol Bioeng | 2025 | 41328303 | PubTator, text mining | PubMed |
| Exploring the significance of GNG11, LPAR1, and AGTR1 in early diagnosis and prognosis of cervical cancer: A correlative analysis with clinical characteristics. | Pak J Med Sci | 2025 | 41244534 | PubTator, text mining | PubMed |
| Lysophosphatidic acid promotes endometrial decidualization in recurrent implantation failure patients by regulating LPAR6. | Front Cell Dev Biol | 2025 | 41199770 | PubTator, text mining | PubMed |
| TNF promotes osteoclastogenesis by secreting miR-31-5p into small extracellular vesicles via the autotaxin-LPA-LPAR1 axis in arthritic fibroblast-like synoviocytes. | Arch Biochem Biophys | 2025 | 41043572 | PubTator, text mining | PubMed |
| The protective mechanism of taurine deoxycholic acid (TCDCA) through LPAR1 regulation in Buga syndrome. | Eur J Med Res | 2025 | 41029443 | PubTator, text mining | PubMed |
| And… cut! - how conformational regulation of CRISPR-Cas effectors directs nuclease activity. | Biochem J | 2025 | 40996239 | PubTator, text mining | PubMed |
| Gamma smooth muscle actin as a new potential marker of cancer-associated fibroblasts. | Histochem Cell Biol | 2025 | 40971055 | PubTator, text mining | PubMed |
| The LPAR1 antagonist, PIPE-791 produces antifibrotic effects in models of lung fibrosis. | Respir Res | 2025 | 40887574 | PubTator, text mining | PubMed |
| Whole-genome methylation profiling of extracellular vesicle DNA in gastric cancer identifies intercellular communication features. | Nat Commun | 2025 | 40883299 | PubTator, text mining | PubMed |
| Study on differentially expressed genes and pattern recognition receptors in osteoporosis based on bioinformatics analysis. | Sci Rep | 2025 | 40854963 | PubTator, text mining | PubMed |
| A molecular systems architecture of the mesenchymal stromal cell microenvironment. | Stem Cells | 2025 | 40843515 | PubTator, text mining | PubMed |
| CircRNAs: functions and emerging roles in cancer and immunotherapy. | BMC Med | 2025 | 40817061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1902/papers?page=3